ReviewFrontiers in oncology2022

Advances in the Application of Radionuclide-Labeled HER2 Affibody for the Diagnosis and Treatment of Ovarian Cancer.

Xianwen Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.